Literature DB >> 2622858

The beagle dog as an animal model for a bioavailability study of controlled-release theophylline under the influence of food.

G K Shiu1, A LeMarchand, A O Sager, R B Velagapudi, J P Skelly.   

Abstract

Beagle dogs were evaluated as an animal model to study the effect of food on the bioavailability of two commercially available oral controlled-release theophylline products. The products were administered with and without food in single doses, and the bioavailability parameters were compared with those following an i.v. aminophylline dose. The total plasma theophylline clearance in dogs following an i.v. dose was 0.128 liter/hr/kg and the volume of distribution was 0.8 liter/kg using a one-compartment model. The absolute bioavailabilities of these two products under fasting conditions were 31 and 48%, respectively. The food increased the bioavailability of one product and decreased the bioavailability of the other. The overall trends in relative bioavailability of these two products with and without food appeared to be similar to those reported in humans.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2622858     DOI: 10.1023/a:1015926403959

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Per cent absorbed time plots derived from blood level and/or urinary excretion data.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1963-06       Impact factor: 3.534

2.  Effects of food on the bioavailability of theophylline from controlled-release products in adults.

Authors:  A Karim
Journal:  J Allergy Clin Immunol       Date:  1986-10       Impact factor: 10.793

3.  Slow release theophylline in patients with airways obstruction with particular reference to the effects of food upon serum levels.

Authors:  P J Thompson; M W Kemp; W A McAllister; M Turner-Warwick
Journal:  Br J Dis Chest       Date:  1983-07

4.  Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet.

Authors:  M Lagas; J H Jonkman
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.

Authors:  N H Leeds; P Gal; A A Purohit; J B Walter
Journal:  J Clin Pharmacol       Date:  1982-04       Impact factor: 3.126

6.  The effect of food on the absorption of controlled-release theophylline in mini-swine.

Authors:  G K Shiu; A O Sager; R B Velagapudi; V K Prasad; J P Skelly
Journal:  Pharm Res       Date:  1988-01       Impact factor: 4.200

7.  Theophylline QID, TID, BID and now QD? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24.

Authors:  M M Weinberger
Journal:  Pharmacotherapy       Date:  1984 Jul-Aug       Impact factor: 4.705

8.  Food-induced changes in theophylline absorption from controlled-release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo-Dur Sprinkle.

Authors:  A Karim; T Burns; L Wearley; J Streicher; M Palmer
Journal:  Clin Pharmacol Ther       Date:  1985-07       Impact factor: 6.875

9.  Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity.

Authors:  L Hendeles; M Weinberger; G Milavetz; M Hill; L Vaughan
Journal:  Chest       Date:  1985-06       Impact factor: 9.410

10.  Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs.

Authors:  V I Vashi; M C Meyer
Journal:  J Pharm Sci       Date:  1988-09       Impact factor: 3.534

View more
  1 in total

Review 1.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.